Overview

Sitosterolemia Extension Study (0653-003)(COMPLETED)

Status:
Completed
Trial end date:
2004-11-30
Target enrollment:
Participant gender:
Summary
This is an extension study for patients having unusually high absorption of non-cholesterol sterols, resulting in heart-related diseases. This study will evaluate the long term safety and the ability to lower cholesterol levels with an investigational drug.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Ezetimibe